
FDA Approves Acoltremon Ophthalmic Solution (TRYPTYR) for Dry Eye Disease
The US Food and Drug Administration (FDA) has approved acoltremon ophthalmic solution .003% (TRYPTYR), formerly AR-15512, a first-in-class transient receptor potential melastatin 8 channel (TRPM8) receptor agonist that stimulates corneal sensory nerves, to …